FR2856296A1 - COSMETIC CARE PROCESS WHICH COMBINES A MECHANICAL EFFECT, RESULTING FROM A MASSAGE, WITH BIOLOGICAL EFFECTS IN COMPLEMENT OR RELAY - Google Patents
COSMETIC CARE PROCESS WHICH COMBINES A MECHANICAL EFFECT, RESULTING FROM A MASSAGE, WITH BIOLOGICAL EFFECTS IN COMPLEMENT OR RELAY Download PDFInfo
- Publication number
- FR2856296A1 FR2856296A1 FR0307339A FR0307339A FR2856296A1 FR 2856296 A1 FR2856296 A1 FR 2856296A1 FR 0307339 A FR0307339 A FR 0307339A FR 0307339 A FR0307339 A FR 0307339A FR 2856296 A1 FR2856296 A1 FR 2856296A1
- Authority
- FR
- France
- Prior art keywords
- active
- massage
- skin
- cosmetic
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 32
- 230000000694 effects Effects 0.000 title claims abstract description 16
- 230000004071 biological effect Effects 0.000 title claims abstract description 7
- 230000000295 complement effect Effects 0.000 title claims description 6
- 230000008569 process Effects 0.000 title description 5
- 238000004353 relayed correlation spectroscopy Methods 0.000 title 1
- 230000002040 relaxant effect Effects 0.000 claims abstract description 16
- 238000011282 treatment Methods 0.000 claims abstract description 8
- 230000004089 microcirculation Effects 0.000 claims abstract description 7
- 230000037303 wrinkles Effects 0.000 claims abstract description 6
- 230000007547 defect Effects 0.000 claims abstract description 5
- 208000032544 Cicatrix Diseases 0.000 claims abstract description 3
- 230000004913 activation Effects 0.000 claims abstract description 3
- 231100000241 scar Toxicity 0.000 claims abstract description 3
- 230000037387 scars Effects 0.000 claims abstract description 3
- 210000003491 skin Anatomy 0.000 claims description 35
- 239000000203 mixture Substances 0.000 claims description 26
- 239000003795 chemical substances by application Substances 0.000 claims description 25
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 24
- 150000001875 compounds Chemical class 0.000 claims description 21
- 239000013543 active substance Substances 0.000 claims description 17
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 claims description 16
- GLZPCOQZEFWAFX-UHFFFAOYSA-N KU0063794 Natural products CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims description 16
- 239000003937 drug carrier Substances 0.000 claims description 14
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 claims description 13
- 229940087305 limonene Drugs 0.000 claims description 12
- 235000001510 limonene Nutrition 0.000 claims description 12
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- -1 methyl dihydrocinnamic aldehyde Chemical compound 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 159000000007 calcium salts Chemical class 0.000 claims description 9
- 235000019441 ethanol Nutrition 0.000 claims description 9
- 210000001519 tissue Anatomy 0.000 claims description 9
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims description 8
- 239000005792 Geraniol Substances 0.000 claims description 8
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 8
- 229940113087 geraniol Drugs 0.000 claims description 8
- 229940067107 phenylethyl alcohol Drugs 0.000 claims description 8
- PHXATPHONSXBIL-UHFFFAOYSA-N xi-gamma-Undecalactone Chemical compound CCCCCCCC1CCC(=O)O1 PHXATPHONSXBIL-UHFFFAOYSA-N 0.000 claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 7
- VPKMGDRERYMTJX-CMDGGOBGSA-N 1-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-1-penten-3-one Chemical compound CCC(=O)\C=C\C1C(C)=CCCC1(C)C VPKMGDRERYMTJX-CMDGGOBGSA-N 0.000 claims description 6
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 claims description 6
- 150000001299 aldehydes Chemical class 0.000 claims description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 6
- 239000006185 dispersion Substances 0.000 claims description 6
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 claims description 6
- BOPPSUHPZARXTH-UHFFFAOYSA-N ocean propanal Chemical compound O=CC(C)CC1=CC=C2OCOC2=C1 BOPPSUHPZARXTH-UHFFFAOYSA-N 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 claims description 5
- 230000001153 anti-wrinkle effect Effects 0.000 claims description 5
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 5
- 210000002615 epidermis Anatomy 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 claims description 4
- MBDOYVRWFFCFHM-SNAWJCMRSA-N (2E)-hexenal Chemical compound CCC\C=C\C=O MBDOYVRWFFCFHM-SNAWJCMRSA-N 0.000 claims description 4
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 claims description 4
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 claims description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- HGDVHRITTGWMJK-UHFFFAOYSA-N 2,6-dimethylheptan-2-ol Chemical compound CC(C)CCCC(C)(C)O HGDVHRITTGWMJK-UHFFFAOYSA-N 0.000 claims description 4
- ZARFDQHJMNVNLE-UITAMQMPSA-N 3-methylbutyl (z)-2-methylbut-2-enoate Chemical compound C\C=C(\C)C(=O)OCCC(C)C ZARFDQHJMNVNLE-UITAMQMPSA-N 0.000 claims description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 4
- XDEGQMQKHFPBEW-UHFFFAOYSA-N Angelicasaeure-isobutylester Natural products CC=C(C)C(=O)OCC(C)C XDEGQMQKHFPBEW-UHFFFAOYSA-N 0.000 claims description 4
- ZARFDQHJMNVNLE-UHFFFAOYSA-N Angelinsaeure-isoamylester Natural products CC=C(C)C(=O)OCCC(C)C ZARFDQHJMNVNLE-UHFFFAOYSA-N 0.000 claims description 4
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 claims description 4
- XDEGQMQKHFPBEW-YVMONPNESA-N Isobutyl angelate Chemical compound C\C=C(\C)C(=O)OCC(C)C XDEGQMQKHFPBEW-YVMONPNESA-N 0.000 claims description 4
- 241000234269 Liliales Species 0.000 claims description 4
- 241000209140 Triticum Species 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- 229960000458 allantoin Drugs 0.000 claims description 4
- UZFLPKAIBPNNCA-UHFFFAOYSA-N alpha-ionone Natural products CC(=O)C=CC1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-UHFFFAOYSA-N 0.000 claims description 4
- UZFLPKAIBPNNCA-BQYQJAHWSA-N alpha-ionone Chemical compound CC(=O)\C=C\C1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-BQYQJAHWSA-N 0.000 claims description 4
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 claims description 4
- 210000004556 brain Anatomy 0.000 claims description 4
- 229940043350 citral Drugs 0.000 claims description 4
- 229940043259 farnesol Drugs 0.000 claims description 4
- 229930002886 farnesol Natural products 0.000 claims description 4
- PHXATPHONSXBIL-JTQLQIEISA-N gamma-Undecalactone Natural products CCCCCCC[C@H]1CCC(=O)O1 PHXATPHONSXBIL-JTQLQIEISA-N 0.000 claims description 4
- IFYYFLINQYPWGJ-UHFFFAOYSA-N gamma-decalactone Chemical compound CCCCCCC1CCC(=O)O1 IFYYFLINQYPWGJ-UHFFFAOYSA-N 0.000 claims description 4
- 229940020436 gamma-undecalactone Drugs 0.000 claims description 4
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 claims description 4
- JHEPBQHNVNUAFL-UHFFFAOYSA-N hex-1-en-1-ol Chemical compound CCCCC=CO JHEPBQHNVNUAFL-UHFFFAOYSA-N 0.000 claims description 4
- UFLHIIWVXFIJGU-UHFFFAOYSA-N hex-3-en-1-ol Natural products CCC=CCCO UFLHIIWVXFIJGU-UHFFFAOYSA-N 0.000 claims description 4
- 230000000887 hydrating effect Effects 0.000 claims description 4
- WPFVBOQKRVRMJB-UHFFFAOYSA-N hydroxycitronellal Chemical compound O=CCC(C)CCCC(C)(C)O WPFVBOQKRVRMJB-UHFFFAOYSA-N 0.000 claims description 4
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 4
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- SDQFDHOLCGWZPU-UHFFFAOYSA-N lilial Chemical compound O=CC(C)CC1=CC=C(C(C)(C)C)C=C1 SDQFDHOLCGWZPU-UHFFFAOYSA-N 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 239000000419 plant extract Substances 0.000 claims description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 4
- 229910052710 silicon Inorganic materials 0.000 claims description 4
- 239000010703 silicon Substances 0.000 claims description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- LICNQDPDQQOXCU-FYJFLYSWSA-N 3-Hydroxy-beta-ionone Natural products CC(=O)\C=C\C1=C(C)[C@@H](O)CCC1(C)C LICNQDPDQQOXCU-FYJFLYSWSA-N 0.000 claims description 3
- 206010001488 Aggression Diseases 0.000 claims description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000000443 aerosol Substances 0.000 claims description 3
- 230000016571 aggressive behavior Effects 0.000 claims description 3
- 210000003403 autonomic nervous system Anatomy 0.000 claims description 3
- 229960001948 caffeine Drugs 0.000 claims description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 229940019836 cyclamen aldehyde Drugs 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- HFRZSVYKDDZRQY-UHFFFAOYSA-N rac-3-Hydroxy-beta-ionone Natural products CC(=O)C=CC1=C(C)CC(O)CC1(C)C HFRZSVYKDDZRQY-UHFFFAOYSA-N 0.000 claims description 3
- 230000001953 sensory effect Effects 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 229940042585 tocopherol acetate Drugs 0.000 claims description 3
- ZFNVDHOSLNRHNN-UHFFFAOYSA-N xi-3-(4-Isopropylphenyl)-2-methylpropanal Chemical compound O=CC(C)CC1=CC=C(C(C)C)C=C1 ZFNVDHOSLNRHNN-UHFFFAOYSA-N 0.000 claims description 3
- MMFCJPPRCYDLLZ-CMDGGOBGSA-N (2E)-dec-2-enal Chemical compound CCCCCCC\C=C\C=O MMFCJPPRCYDLLZ-CMDGGOBGSA-N 0.000 claims description 2
- YGFGZTXGYTUXBA-UHFFFAOYSA-N (±)-2,6-dimethyl-5-heptenal Chemical compound O=CC(C)CCC=C(C)C YGFGZTXGYTUXBA-UHFFFAOYSA-N 0.000 claims description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- 229940022663 acetate Drugs 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims description 2
- 239000012190 activator Substances 0.000 claims description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 2
- 229940007550 benzyl acetate Drugs 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 2
- MMFCJPPRCYDLLZ-UHFFFAOYSA-N dec-2-enal Natural products CCCCCCCC=CC=O MMFCJPPRCYDLLZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 229930186222 escin Natural products 0.000 claims description 2
- 229940011399 escin Drugs 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 229930003935 flavonoid Natural products 0.000 claims description 2
- 150000002215 flavonoids Chemical class 0.000 claims description 2
- 235000017173 flavonoids Nutrition 0.000 claims description 2
- IFYYFLINQYPWGJ-VIFPVBQESA-N gamma-Decalactone Natural products CCCCCC[C@H]1CCC(=O)O1 IFYYFLINQYPWGJ-VIFPVBQESA-N 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 2
- 235000011477 liquorice Nutrition 0.000 claims description 2
- KVWWIYGFBYDJQC-UHFFFAOYSA-N methyl dihydrojasmonate Chemical compound CCCCCC1C(CC(=O)OC)CCC1=O KVWWIYGFBYDJQC-UHFFFAOYSA-N 0.000 claims description 2
- DNCPZJXUBYQFED-UHFFFAOYSA-N nona-3,5-dien-1-ol Chemical compound CCCC=CC=CCCO DNCPZJXUBYQFED-UHFFFAOYSA-N 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 235000005985 organic acids Nutrition 0.000 claims description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 2
- 229920005862 polyol Polymers 0.000 claims description 2
- 150000003077 polyols Chemical class 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 claims description 2
- 229960004889 salicylic acid Drugs 0.000 claims description 2
- 239000012265 solid product Substances 0.000 claims description 2
- 235000000346 sugar Nutrition 0.000 claims description 2
- 150000008163 sugars Chemical class 0.000 claims description 2
- MBDOYVRWFFCFHM-UHFFFAOYSA-N trans-2-hexenal Natural products CCCC=CC=O MBDOYVRWFFCFHM-UHFFFAOYSA-N 0.000 claims description 2
- 235000019155 vitamin A Nutrition 0.000 claims description 2
- 239000011719 vitamin A Substances 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 229940045997 vitamin a Drugs 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229960004275 glycolic acid Drugs 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 abstract description 4
- 230000019522 cellular metabolic process Effects 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 230000009471 action Effects 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000004909 Moisturizer Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 230000001333 moisturizer Effects 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 230000003387 muscular Effects 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- WCGUUGGRBIKTOS-GPOJBZKASA-M (1s,2r,4as,6ar,6as,6br,8ar,10s,12ar,14bs)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1h-picene-4a-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C([O-])=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-M 0.000 description 3
- 210000001789 adipocyte Anatomy 0.000 description 3
- 229960005069 calcium Drugs 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 230000036642 wellbeing Effects 0.000 description 3
- QZLXCFQVOCEKSX-NOCHOARKSA-N (2s,4r)-1-hexadecanoyl-4-hexadecanoyloxypyrrolidine-2-carboxylic acid Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@H]1C[C@@H](C(O)=O)N(C(=O)CCCCCCCCCCCCCCC)C1 QZLXCFQVOCEKSX-NOCHOARKSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 229940100554 isononyl isononanoate Drugs 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 239000008279 sol Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- DHFUFHYLYSCIJY-WSGIOKLISA-N CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O Chemical compound CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DHFUFHYLYSCIJY-WSGIOKLISA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000612153 Cyclamen Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 239000004904 UV filter Substances 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229930186364 cyclamen Natural products 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001652 frontal lobe Anatomy 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012764 mineral filler Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940086539 peg-7 glyceryl cocoate Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000003304 psychophysiological effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000037331 wrinkle reduction Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
L'invention concerne un procédé de soin cosmétique permettant d'amplifier ou de prolonger l'incidence des effets mécaniques et stimulant du métabolisme cellulaire résultant d'un massage, caractérisé en ce qu'il conjugue ces effets résultant d'un massage à des effets biologiques en complément ou en relais, lesdits effets biologiques étant apportés par application sur la peau d'une base galénique active comprenant au moins une fraction volatile parfumée à effet relaxant. L'invention concerne également un méthode de traitement mettant en oeuvre ledit procédé, pour l'une quelconque des fins suivantes, à savoir :- amincissement de toute partie superficielle du corps humain,- atténuation des rides,- raffermissement et tonification des tissus,- activation de la microcirculation,drainage,- atténuation ou effacement des cicatrices et défauts cutanésThe invention relates to a cosmetic care method for amplifying or prolonging the incidence of mechanical effects and stimulating cellular metabolism resulting from a massage, characterized in that it combines these effects resulting from a massage with effects biological supplement or relay, said biological effects being provided by application to the skin of an active dosage base comprising at least one volatile fragrant fraction with a relaxing effect. The invention also relates to a treatment method implementing said method, for any one of the following purposes, namely: - thinning of any superficial part of the human body, - attenuation of wrinkles, - firming and toning of tissues, - activation of microcirculation, drainage, - attenuation or erasing of scars and skin defects
Description
La présente invention a trait au domaine des traitements cosmétiquesThe present invention relates to the field of cosmetic treatments.
complémentaires ou relais à des techniques de stimulation mécanique de la peau et des tissus comme le massage, celui-ci étant effectué de manière manuelle ou avec une assistance mécanique. complementary or relay to techniques of mechanical stimulation of the skin and tissues such as massage, this being carried out manually or with mechanical assistance.
La peau est un éco-système qui puise dans l'alimentation du sujet, les éléments nécessaires à sa vie, à ses échanges, à la lutte contre les agressions du milieu extérieur et à sa résistance au vieillissement. Les 10 nutriments sont stockés, éliminés et transformés dans l'éco-système cutané. Mal adaptée, I'alimentation n'apporte pas toujours tous les éléments nécessaires (vitamines, oligo-éléments, minéraux) et malmène parfois la structure cutanée (surcharge, stase, distension, pollution). The skin is an eco-system which draws from the subject's food, the elements necessary for his life, his exchanges, the fight against the aggressions of the external environment and his resistance to aging. The 10 nutrients are stored, eliminated and transformed in the skin eco-system. Poorly adapted, food does not always provide all the necessary elements (vitamins, trace elements, minerals) and sometimes mistreats the skin structure (overload, stasis, distension, pollution).
Les muscles sont en étroite relation anatomique avec la peau. Mais 15 souvent mal ou peu sollicités, ils jouent souvent un rôle néfaste sur la circulation sanguine et les échanges. Le " stress ", les tensions altèrent la fluidité des mouvements et accentuent les phénomènes de stockage des toxines, de congestion et de ralentissement circulatoire. The muscles are in close anatomical relationship with the skin. But often poorly or poorly used, they often play a harmful role in blood circulation and exchanges. The "stress", the tensions alter the fluidity of movements and accentuate the phenomena of toxin storage, congestion and circulatory slowdown.
La peau est soutenue par un réseau aponévrotique et musculaire qui participe à sa forme et ses défauts. The skin is supported by a fascial and muscular network which participates in its shape and its defects.
Schématiquement, la peau se compose de trois couches superposées: l'épiderme: il est constitué de plusieurs couches, dont la couche base germinative, la couche de Malpighi et la couche cornée; cette dernière formée de cellules mortes (kératinisées) assure à la peau une protection, - le derme: protégé par l'épiderme, il contrôle la tonicité, l'élasticité 30 et la solidité de la peau; le derme peut se régénérer, il est principalement constitué de fibres de collagène, d'élastine et d'eau, son élasticité est assurée par la présence de l'élastine; ce derme renferme un réseau vasculaire et nerveux très dense, - I'hypoderme: formé de cellules graisseuses (adipocytes) et de 35 tissu conjonctif, il assure la protection des tissus profonds. Schematically, the skin is made up of three superimposed layers: the epidermis: it is made up of several layers, including the germinal base layer, the Malpighi layer and the horny layer; the latter formed from dead (keratinized) cells provides the skin with protection, the dermis: protected by the epidermis, it controls the tone, the elasticity and the solidity of the skin; the dermis can regenerate, it mainly consists of collagen fibers, elastin and water, its elasticity is ensured by the presence of elastin; this dermis contains a very dense vascular and nervous network, - the hypodermis: formed of fat cells (adipocytes) and connective tissue, it provides protection for deep tissue.
En cas d'accumulation de cellulite, ou de variations de poids importantes, les adipocytes se gonflent et se vident avec pour conséquence, une altération de l'élasticité du derme. In the event of accumulation of cellulite, or significant variations in weight, the adipocytes swell and empty with the consequence, an alteration of the elasticity of the dermis.
Sous la peau, on trouve le réseau musculaire. Under the skin is the muscle network.
Si les muscles sont suffisamment toniques, ils soutiennent la peau et activent la circulation sanguine. If the muscles are sufficiently toned, they support the skin and activate blood circulation.
Mais peu ou pas assez entraînés, ils amènent un ramollissement des tissus et l'hypoderme est moins irrigué, le tissu conjonctif se relâche et les 10 défauts apparaissent: relâchement, rides, etc.... But little or not enough trained, they bring a softening of the tissues and the hypodermis is less irrigated, the connective tissue relaxes and the 10 defects appear: sagging, wrinkles, etc ...
On connaît l'efficacité des techniques de massage de la peau ou des parties superficielles du corps humain, qui permettent par une stimulation de la peau et de ses fonctions, de lutter contre la perte d'élasticité et les 15 effets de vieillissement et/ou de relâchement. Ainsi, qu'ils soient manuels ou assistés mécaniquement, outre les actions sur le tissu conjonctif, ils permettent une amélioration de l'aspect esthétique, que ce soit sur le visage par l'atténuation des rides ou du relâchement, ou sur le corps par une diminution des amas graisseux ou cellulitiques, et l'augmentation de la 20 tonicité. The effectiveness of techniques for massaging the skin or superficial parts of the human body, which by stimulating the skin and its functions, is known to combat the loss of elasticity and the effects of aging and / or release. Thus, whether manual or mechanically assisted, in addition to actions on the connective tissue, they allow an improvement in the aesthetic appearance, whether on the face by the reduction of wrinkles or sagging, or on the body by a decrease in fatty or cellulitic clumps, and an increase in tone.
Par " massages assistés mécaniquement ", on entend par exemple des massages effectués avec des appareils comprenant des moyens de commande manuels, comportant une tête de traitement reliée à un circuit d'aspiration, ladite tête de traitement comportant deux surfaces disposées 25 en regard l'une de l'autre et ledit circuit d'aspiration permettant de former par la dépression créée un pli de peau qui sera ensuite déplacé sur la surface du corps humain. By "mechanically assisted massages" is meant, for example, massages carried out with devices comprising manual control means, comprising a treatment head connected to a suction circuit, said treatment head comprising two surfaces arranged opposite the one of the other and said suction circuit making it possible to form, by the depression created, a fold of skin which will then be displaced over the surface of the human body.
A titre d'exemple, on citera les appareils développés par la société française LPG, comme le Cellu M6 ou le Lift6 . Ces appareils permettent 30 d'effectuer des massages spécifiques qui sont obtenus par l'utilisation de têtes de massages reliées à un circuit d'aspiration. Les têtes de massage comprennent un boîtier, une chambre et deux surfaces transversales constituées de rouleaux entraînes positivement en rotation, de tels appareils sont décrits par exemple dans les demandes de brevets français publiés 35 sous les nO FR2579100, FR2589726, FR2612395, FR2723310, FR2752159, FR2768051 et FR2809952. By way of example, mention may be made of the devices developed by the French company LPG, such as the Cellu M6 or the Lift6. These devices make it possible to perform specific massages which are obtained by the use of massage heads connected to a suction circuit. The massage heads include a housing, a chamber and two transverse surfaces made up of rollers driven positively in rotation, such devices are described, for example, in the French patent applications published under Nos. FR2579100, FR2589726, FR2612395, FR2723310, FR2752159, FR2768051 and FR2809952.
De façon surprenante selon la présente invention, il a été mis en évidence un effet synergique entre ces techniques de massage et l'application complémentaire ou en relais, d'une base galénique comprenant au moins une fraction volatile parfumée ayant un effet relaxant, cette base 5 galénique pouvant contenir en outre un agent kératorégulateur et/ou un actif cosmétique. Surprisingly according to the present invention, it has been demonstrated a synergistic effect between these massage techniques and the complementary or relay application of a pharmaceutical base comprising at least one volatile fragrant fraction having a relaxing effect, this base 5 dosage form which may also contain a keratorregulating agent and / or a cosmetic active agent.
La base galénique active agit en complément, en relais et en synergie avec les techniques de massage: - en apportant une détente des muscles sous-cutanés et une détente de l'appareil musculaire, qui favorisent le travail musculaire induit par le massage, - en favorisant le renouvellement de la peau par l'action concomittante de l'agent kératorégulateur vis-à-vis des couches cutanées superficielles, - et en apportant confort et bien-être par l'action de l'actif cosmétique qui pourra être choisi en fonction de la zone et du sujet traité. The active galenic base acts as a complement, in relay and in synergy with massage techniques: - by providing relaxation of the subcutaneous muscles and relaxation of the muscular apparatus, which promote the muscular work induced by massage, - by favoring the renewal of the skin by the concomitant action of the keratorregulating agent vis-à-vis the superficial skin layers, - and by bringing comfort and well-being by the action of the cosmetic active which can be chosen according to of the area and the subject treated.
Cette action à trois niveaux permet ainsi de prolonger et d'augmenter l'efficacité des techniques de massage. This three-level action thus prolongs and increases the effectiveness of massage techniques.
La présente invention concerne un procédé de soin cosmétique permettant d'amplifier ou de prolonger l'incidence des effets mécaniques et stimulant du métabolisme cellulaire résultant d'un massage, caractérisé en ce qu'il conjugue ces effets résultant d'un massage à des effets biologiques en complément ou en relais. The present invention relates to a cosmetic care method for amplifying or prolonging the incidence of mechanical effects and stimulating cellular metabolism resulting from a massage, characterized in that it combines these effects resulting from a massage with effects biological in addition or in relay.
Elle concerne plus particulièrement un procédé tel que défini précédemment, caractérisé en ce que les effets biologiques sont apportés par application sur la peau d'une base galénique active comprenant au moins une fraction volatile parfumée à effet relaxant. It relates more particularly to a process as defined above, characterized in that the biological effects are provided by application to the skin of an active pharmaceutical base comprising at least one volatile fragrant fraction with a relaxing effect.
Dans une variante du procédé la base galénique active comprend en 30 outre un agent kératorégulateur et/ou un actif cosmétique. In a variant of the process, the active galenical base further comprises a keratorregulating agent and / or a cosmetic active agent.
Dans un mode de réalisation l'actif cosmétique est choisi parmi les actifs ayant une action de drainage ou d'activateur de la microcirculation sur l'épiderme. In one embodiment, the cosmetic active ingredient is chosen from active ingredients having a drainage or activating action on the microcirculation on the epidermis.
Elle concerne ainsi un procédé de soin cosmétique, qui conjugue un effet mécanique, résultant d'un massage, à des effets biologiques en complément ou en relais, caractérisé en ce que les effets biologiques sont apportés par application sur la peau d'une base galénique active comprenant une fraction volatile parfumée à effet relaxant, ladite base pouvant contenir en outre un agent kératorégulateur, comprenant par exemple un sel de calcium, et/ou un actif cosmétique. It thus relates to a cosmetic care process, which combines a mechanical effect, resulting from a massage, with biological effects in addition or as a relay, characterized in that the biological effects are provided by application to the skin of a galenical base. active comprising a fragrant volatile fraction with a relaxing effect, said base possibly also containing a keratorregulating agent, comprising for example a calcium salt, and / or a cosmetic active.
On entend par " fraction volatile ", un ou plusieurs composés ou substances susceptibles de s'évaporer et de diffuser dans l'atmosphère des vapeurs susceptibles d'être inhalées. The term "volatile fraction" means one or more compounds or substances capable of evaporating and of diffusing into the atmosphere vapors capable of being inhaled.
On entend par fraction volatile "< parfumée à effet relaxant ", un ou plusieurs composés actifs ou substances actives, ayant des propriétés 10 sensorielles olfactives, odoriférantes, relaxatrices du système nerveux autonome seuls ou en mélange. By volatile fraction is meant "fragrant with relaxing effect", one or more active compounds or active substances, having sensory olfactory, odoriferous, relaxing properties of the autonomic nervous system alone or as a mixture.
On connaît l'action de certains composés ou substances parfumés pour modifier l'augmentation de l'amplitude d'une onde cérébrale f lors de la mesure de la variation négative contingente (en anglais CNV), chez un 15 patient ou sujet, et la corrélation entre cette action et l'effet relaxant neutre ou excitant de ces composés. The action of certain perfumed compounds or substances is known to modify the increase in the amplitude of a brain wave f when measuring the contingent negative variation (in English CNV), in a patient or subject, and the correlation between this action and the neutral or exciting relaxing effect of these compounds.
L'action sur la CNV de certains composés parfumés a été décrite par exemple dans " Psychophysiological effect of odor " C.H. Manley, Critical Reviews of food science and nutrition, CRC Press, 33(1) :57-62, 1993. The action on the CNV of certain perfumed compounds has been described for example in "Psychophysiological effect of odor" C.H. Manley, Critical Reviews of food science and nutrition, CRC Press, 33 (1): 57-62, 1993.
Cette technique est basée sur la mesure d'une onde 3 du cerveau qui réflète le dégré de conscience du patient ou sujet, par la localisation sur le lobe frontal du sujet d'électrodes, qui permettent de détecter et quantifier ainsi la modification de l'augmentation d'amplitude d'une onde A, en fonction du composé odorant inhalé par ledit sujet entre deux stimuli dits 25 S1 (d'avertissement) et S2 (de commande). This technique is based on the measurement of a brain wave 3 which reflects the degree of consciousness of the patient or subject, by the localization on the frontal lobe of the subject of electrodes, which make it possible to detect and thus quantify the modification of the increase in amplitude of an A wave, as a function of the odorous compound inhaled by said subject between two so-called stimuli 25 S1 (warning) and S2 (control).
Cette méthode expérimentale permet ainsi de classer les composés odorants en trois catégories en fonction de l'effet sur cette onde f, lorsque l'amplitude de cette onde est augmentée, à savoir relaxants lorsque cette augmentation d'amplitude se trouve diminuée, stimulants, ou sans effet 30 mesurable, et donc neutres. This experimental method thus makes it possible to classify the odorous compounds in three categories according to the effect on this f wave, when the amplitude of this wave is increased, namely relaxing when this increase in amplitude is reduced, stimulating, or no measurable effect, and therefore neutral.
On entend par " agent kératorégulateur ", un composé ayant un effet sur le renouvellement cellulaire dû à une action kératorégulatrice de certains composés. The term "keratorregulating agent" means a compound having an effect on cell renewal due to a keratoregulatory action of certain compounds.
Cette action kératorégulatrice est mise en évidence par la mesure de l'action d'un composé vis-à-vis d'une culture de kératinocytes, selon une méthode in vitro permettant d'apprécier le pouvoir biologique dudit composé sur la division et la différentiation cellulaire. This keratoregulatory action is demonstrated by measuring the action of a compound vis-à-vis a culture of keratinocytes, according to an in vitro method making it possible to assess the biological power of said compound on division and differentiation cellular.
Cette action kératorégulatrice est due notamment à une induction de la différentiation terminale des kératinocytes. This keratoregulatory action is due in particular to an induction of the terminal differentiation of keratinocytes.
La présence dans la base galénique selon l'invention d'un composé ayant une action kératorégulatrice permet d'obtenir un effet prolongé de 5 l'action du massage sur le renouvellement cellulaire, I'effacement des rides et l'aspect esthétique de la peau. Cette présence permet également de calmer l'épiderme irrité et d'éviter la formation d'érythème. The presence in the galenical base according to the invention of a compound having a keratoregulatory action makes it possible to obtain a prolonged effect of the action of massage on cell renewal, the erasure of wrinkles and the aesthetic appearance of the skin. . This presence also helps calm the irritated epidermis and prevent the formation of erythema.
Cette action est connue par exemple de certains dérivés de calcium et plus particulièrement ses sels. This action is known for example from certain calcium derivatives and more particularly its salts.
On entend par " actif cosmétique ", des composés ou substances actifs destinés a être appliqués sur la peau et permettant en apportant confort et bien-être, de protéger, nettoyer ou corriger les imperfections de celle-ci et améliorer son aspect esthétique. The term "cosmetic active" means compounds or active substances intended to be applied to the skin and making it possible, by providing comfort and well-being, to protect, cleanse or correct the imperfections thereof and improve its aesthetic appearance.
Parmi les actifs cosmétiques, on citera par exemple les hydratants, les apaisants, les relaxants, les anti-rides, les tenseurs, les amincissants, les agents lipolytiques, les agents drainants, les adoucissants, les vitamines, les acides gras essentiels. Among the cosmetic active agents, mention may be made, for example, of moisturizers, soothing agents, relaxants, anti-wrinkles, tensors, slimming agents, lipolytic agents, draining agents, softeners, vitamins and essential fatty acids.
Dans le procédé selon l'invention, le massage est effectué le cas échéant, avec une assistance mécanique, contrôlée manuellement par un opérateur. In the method according to the invention, the massage is carried out if necessary, with mechanical assistance, manually controlled by an operator.
L'assistance mécanique permet par exemple de former et déplacer un pli cutané sur la surface du corps humain et d'obtenir un enroulé déroulé 25 des tissus cutanés; cet enroulé déroulé des tissus cutanés étant obtenu par l'utilisation de têtes de massage reliées à un circuit d'aspiration. Mechanical assistance makes it possible, for example, to form and move a skin fold on the surface of the human body and to obtain an unwound rolled up of skin tissue; this unwound rolled up of skin tissue being obtained by the use of massage heads connected to a suction circuit.
Dans une variante du procédé le massage est effectué de manière manuelle, sans assistance mécanique. 30 Selon le procédé selon l'invention, on applique la base galénique active sur toute la surface de la peau soumise à l'opération de massage. In a variant of the process, the massage is carried out manually, without mechanical assistance. According to the method according to the invention, the active pharmaceutical base is applied to the entire surface of the skin subjected to the massage operation.
L'invention concerne également une méthode de traitement de toute 35 partie superficielle du corps humain, à des fins cosmétiques ou hygiéniques, mettant en oeuvre un procédé tel que décrit précédemment. The invention also relates to a method of treatment of any surface part of the human body, for cosmetic or hygienic purposes, using a method as described above.
Ladite méthode de traitement selon l'invention est appliquée pour l'une quelconque des fins suivantes, à savoir: - amincissement de toute partie superficielle du corps humain, - atténuation des rides, - raffermissement et tonification des tissus, - activation de la microcirculation, drainage, -atténuation ou effacement des cicatrices et défauts cutanés L'invention concerne également une base galénique active, caractérisée en ce qu'elle comprend une fraction volatile parfumée à effet relaxant. Said treatment method according to the invention is applied for any one of the following purposes, namely: - thinning of any superficial part of the human body, - attenuation of wrinkles, - firming and toning of tissues, - activation of microcirculation, drainage, attenuation or erasing of scars and skin defects The invention also relates to an active galenic base, characterized in that it comprises a volatile fragrant fraction with a relaxing effect.
Elle concerne également une base galénique active telle que 15 précédemment définie, caractérisée en ce qu'elle comprend en outre un agent kératorégulateur et/ou un actif cosmétique. It also relates to an active galenic base as defined above, characterized in that it also comprises a keratorregulating agent and / or a cosmetic active.
L'invention concerne également une base galénique active, caractérisée en ce qu'elle comprend une fraction volatile parfumée à effet 20 relaxant, au moins un agent kératorégulateur comprenant un sel de calcium et un actif cosmétique. The invention also relates to an active galenic base, characterized in that it comprises a volatile fragrant fraction with a relaxing effect, at least one keratorregulating agent comprising a calcium salt and a cosmetic active.
Une base galènique selon l'invention apporte une détente des muscles souscutanés et une détente de l'appareil musculaire, qui favorisent le 25 travail musculaire induit par le massage, favorise le renouvellement de la peau par l'action concomittante de l'agent kératorégulateur vis-à-vis des couches cutanées superficielles, et apporte confort et bien-être par l'action de l'actif cosmétique. A galenical base according to the invention provides relaxation of the subcutaneous muscles and relaxation of the muscular apparatus, which promote the muscular work induced by massage, promotes the renewal of the skin by the concomitant action of the keratorregulating agent vis -to the surface skin layers, and provides comfort and well-being through the action of the cosmetic active.
Préférentiellement, la fraction volatile parfumée à effet relaxant comprend un composé actif ou substance active ayant des propriétés sensorielles olfactives, odoriférantes, relaxatrices du système nerveux autonome. Preferably, the fragrant volatile fraction with a relaxing effect comprises an active compound or active substance having olfactory, odoriferous, relaxing sensory properties of the autonomic nervous system.
A titre d'exemple, la fraction volatile parfumée est formulée dans la 35 base galénique active selon l'invention, pour que cette dernière génère une diminution de l'augmentation de l'amplitude d'une onde cérébrale f3, par exemple d'au moins 10%, lors de la mesure de la CNV chez tout sur lequel ladite composition est appliquée, par exemple étalée. By way of example, the fragrant volatile fraction is formulated in the active pharmaceutical base according to the invention, so that the latter generates a decrease in the increase in the amplitude of a brain wave f3, for example at least minus 10%, when measuring CNV in everything on which said composition is applied, for example spread.
L'invention concerne également une base galénique active, caractérisée en ce que la fraction volatile parfumée comprend au moins un composé ou substance choisi dans le groupe constitué par les composés suivants: Trans-2-décénal; Aldéhyde cyclamen, hydroxycitronellal et hexen-1-ol; Méthyl ionone et 2-6,nonadien-1-ol; géraniol et alcool phényl éthylique; limonène; gamma undécalactone; melonal; trans-2-hexenal; acétat de linalyle; 2,6-diméthyl-2-heptanol; gamma décalactone et 3-hydroxy-210 butanone et beta ionone; hédione et Hélional; limonène et aldéhydes C8 à C10; limonène et citral, acétate de linalyle; angélate d'isoamyle et angélate d'isobutyle; farnésol, acétate de benzyle et hélional, cis3hexenol, alpha-ionone et beta-ionone et methyl-ionone, alcool phényléthylique, indole et lilial (para-tert-butyl alpha methyl dihydrocinnamique 15 aldéhyde), géraniol et alcool phényl éthylique. The invention also relates to an active galenic base, characterized in that the volatile perfumed fraction comprises at least one compound or substance chosen from the group consisting of the following compounds: Trans-2-decenal; Cyclamen aldehyde, hydroxycitronellal and hexen-1-ol; Methyl ionone and 2-6, nonadien-1-ol; geraniol and phenyl ethyl alcohol; limonene; gamma undecalactone; melonal; trans-2-hexenal; linalyl acetate; 2,6-dimethyl-2-heptanol; gamma decalactone and 3-hydroxy-210 butanone and beta ionone; hédione and Hélional; limonene and C8 to C10 aldehydes; limonene and citral, linalyl acetate; isoamyl angelate and isobutyl angelate; farnesol, benzyl and helional acetate, cis3hexenol, alpha-ionone and beta-ionone and methyl-ionone, phenylethyl alcohol, indole and lilial (para-tert-butyl alpha methyl dihydrocinnamic aldehyde), geraniol and phenyl ethyl alcohol.
Elle concerne également une base galénique active caractérisée en ce que la fraction volatile parfumée a l'une des compositions suivantes Composition N 01: Aldéhyde cyclamen, hydroxycitronellal et hexen-1-ol; géraniol et alcool phényl éthylique; limonène; 2,6-diméthyl-2-heptanol; gamma undécalactone et 3-hydroxy-2-butanone et beta-ionone; hédione et hélional; limonène et aldéhydes C8 à C10; limonène et citral. It also relates to an active galenic base, characterized in that the volatile perfumed fraction has one of the following compositions Composition N 01: Aldehyde cyclamen, hydroxycitronellal and hexen-1-ol; geraniol and phenyl ethyl alcohol; limonene; 2,6-dimethyl-2-heptanol; gamma undecalactone and 3-hydroxy-2-butanone and beta-ionone; hedione and helional; limonene and C8 to C10 aldehydes; limonene and citral.
Composition N0 2: acétate de linalyle; angélate d'isoamyle et angélate d'isobutyle; farnésol, acétate de benzyle et hélional Composition N0 3: Cis-3-hexenol, alpha-ionone et beta-ionone et methyl-ionone, alcool phényl éthylique, indole et lilial (para-tert-butyl alpha methyl dihydrocinnamique 30 aldéhyde), géraniol et alcool phényl éthylique. Composition NO 2: linalyl acetate; isoamyl angelate and isobutyl angelate; farnesol, benzyl acetate and helional Composition N0 3: Cis-3-hexenol, alpha-ionone and beta-ionone and methyl-ionone, ethyl phenyl alcohol, indole and lilial (para-tert-butyl alpha methyl dihydrocinnamique 30 aldehyde), geraniol and ethyl phenyl alcohol.
L'invention concerne ainsi une base galénique active, caractérisée en ce que le composé kératorégulateur est un sel de calcium choisi dans le groupe constitué par les sels de calcium des acides organiques comme 35 lI'acide ursolique, gluconique, citrique, glycolique, pyrrolidonecarboxylique, salicylique, et les sels de calcium des acides minéraux comme l'acide chlorhydrique ou carbonique seuls ou en mélange. The invention thus relates to an active galenic base, characterized in that the keratorregulating compound is a calcium salt chosen from the group consisting of calcium salts of organic acids such as ursolic, gluconic, citric, glycolic, pyrrolidonecarboxylic acid, salicylic acid, and calcium salts of mineral acids such as hydrochloric or carbonic acid, alone or as a mixture.
De préférence, ces sels de calcium seuls ou en mélange seront présents dans la base galénique active selon l'invention, dans un pourcentage pondéral compris entre 0.01% et 25%. Preferably, these calcium salts, alone or as a mixture, will be present in the active galenical base according to the invention, in a weight percentage of between 0.01% and 25%.
L'invention concerne également une base galénique active caractérisée en ce que l'actif cosmétique est choisi parmi les agents hydratants comme les polyols notamment le xylitol, la glycérine et ou les tenseurs hydratants comme la liftiline () (peptide de blé) et les protéines végétales. The invention also relates to an active pharmaceutical base, characterized in that the cosmetic active agent is chosen from hydrating agents such as polyols, in particular xylitol, glycerin and or hydrating tensors such as liftiline () (wheat peptide) and proteins. plant.
Elle concerne également une base galénique active caractérisée en ce que l'actif cosmétique est un adoucissant et/ou un apaisant choisi parmi l'allantoïne, la vitamine E, les extraits de réglisse, les extraits végétaux, les peptides et les sucres. It also relates to an active galenic base characterized in that the cosmetic active agent is a softener and / or a soothing agent chosen from allantoin, vitamin E, liquorice extracts, plant extracts, peptides and sugars.
Elle concerne également une base galénique active caractérisée en ce que l'actif cosmétique est un agent antiride, restructurant, raffermissant ou un agent antiradicalaire permettant de protéger la peau des agressions extérieures, par exemple la vitamine A, I'algisium C (silicium organique) ou 20 I'acétate de tocophérol. It also relates to an active galenic base characterized in that the cosmetic active agent is an anti-wrinkle, restructuring, firming agent or an anti-free radical agent making it possible to protect the skin from external aggressions, for example vitamin A, algisium C (organic silicon) or tocopherol acetate.
Elle concerne également une base galénique active caractérisée en ce que l'actif cosmétique est un agent amincissant, comprenant par exemple un lipoactivateur comme la caféine, et/ou un activateur de la 25 microcirculation comme l'escine, les flavonoides, les extraits végétaux ou obtenus par biotechnologie. It also relates to an active galenic base characterized in that the cosmetic active agent is a slimming agent, comprising for example a lipoactivator such as caffeine, and / or an activator of the microcirculation such as escin, flavonoids, plant extracts or obtained by biotechnology.
La base galénique selon l'invention peut se présenter sous toutes les formes galéniques appropriées pour une application topique, notamment 30 sous forme de solution aqueuse, hydroalcoolique, organique ou huileuse; de suspension ou de dispersion dans des solvants ou des corps gras, de type lotion ou sérum; sous forme de dispersion vésiculaire; sous forme d'émulsion E/H, H/E ou multiple, telle qu'une crème ou un lait; sous forme de pommade, de gel, de bâtonnet solide, de produits anhydres pâteux ou 35 solides, de mousse, notamment aérosol ou de " spray ". The pharmaceutical base according to the invention may be in all the pharmaceutical forms suitable for topical application, in particular in the form of an aqueous, hydroalcoholic, organic or oily solution; suspension or dispersion in solvents or fatty substances, of lotion or serum type; in the form of a vesicular dispersion; in the form of a W / O, O / W or multiple emulsion, such as a cream or a milk; in the form of an ointment, gel, solid stick, pasty or solid anhydrous products, foam, in particular aerosol or "spray".
Notamment, la base galénique peut comprendre tout corps gras usuellement utilisé dans le domaine d'application envisagé. On peut notamment citer les corps gras silicones tels que les huiles, les gommes et les cires de silicone, ainsi que les corps gras non silicones tels que les huiles et les cires d'origine végétale, minérale, animale et/ou synthétique. In particular, the pharmaceutical base can comprise any fatty substance usually used in the field of application envisaged. Mention may in particular be made of silicone fatty substances such as oils, gums and silicone waxes, as well as non-silicone fatty substances such as oils and waxes of vegetable, mineral, animal and / or synthetic origin.
Les huiles peuvent éventuellement être volatiles ou non volatiles. On peut 5 encore citer les hydrocarbures, les esters et les éthers de synthèse, les alcools gras et les acides gras. La base galénique peut également comprendre un milieu aqueux, un milieu hydro-alcoolique contenant un alcool tel que l'éthanol ou l'isopropanol, ou un milieu organique comprenant des solvants organiques usuels tels que des alcools en C16, notamment 10 l'éthanol et l'isopropanol, des glycols tels que le propylène glycol, des cétones. The oils can optionally be volatile or non-volatile. Mention may also be made of hydrocarbons, synthetic esters and ethers, fatty alcohols and fatty acids. The pharmaceutical base can also comprise an aqueous medium, a hydroalcoholic medium containing an alcohol such as ethanol or isopropanol, or an organic medium comprising usual organic solvents such as C 16 alcohols, in particular ethanol and isopropanol, glycols such as propylene glycol, ketones.
La base galénique peut comprendre au moins un émulsionnant classique, choisi parmi les émulsionnants amphotères, anioniques, 15 cationiques, ou non ioniques, utilisés seuls ou en mélange. The pharmaceutical base can comprise at least one conventional emulsifier, chosen from amphoteric, anionic, cationic or nonionic emulsifiers, used alone or as a mixture.
Elle peut également comprendre les adjuvants habituels dans le domaine considéré, tels que les épaississants ou gélifiants hydrophiles ou lipophiles, les additifs hydrophiles ou lipophiles, des polymères liposolubles 20 notamment hydrocarbonés, les opacifiants, les stabilisants, les séquestrants, les conditionneurs, et les agents propulseurs. It can also include the usual adjuvants in the field under consideration, such as hydrophilic or lipophilic thickeners or gelling agents, hydrophilic or lipophilic additives, liposoluble polymers, in particular hydrocarbon-based, opacifiers, stabilizers, sequestrants, conditioners, and agents thrusters.
Bien entendu l'homme du métier veillera à choisir ce ou ces éventuels adjuvants, et/ou leur quantité, de manière telle que les propriétés 25 avantageuses de la base galénique selon l'invention ne soient pas, ou substantiellement pas, altérées par l'adjonction envisagée. Of course, a person skilled in the art will take care to choose this or these optional adjuvants, and / or their quantity, in such a way that the advantageous properties of the galenic base according to the invention are not, or not substantially, affected by the planned addition.
L'invention concerne ainsi également une base galénique active, caractérisée en ce qu'elle est sous une forme choisie dans le groupe 30 constitué par une solution aqueuse, hydroalcoolique, organique ou huileuse; une suspension ou une dispersion dans des solvants ou des corps gras, une lotion ou sérum; une dispersion vésiculaire; une émulsion E/H, H/E ou multiple telle qu'une crème ou un lait; une pommade, un gel, des produits anhydres pâteux ou solides, une mousse notamment un aérosol ou un 35 spray. The invention thus also relates to an active galenic base, characterized in that it is in a form chosen from group 30 consisting of an aqueous, hydroalcoholic, organic or oily solution; a suspension or dispersion in solvents or fatty substances, a lotion or serum; a vesicular dispersion; a W / O, O / W or multiple emulsion such as a cream or milk; an ointment, a gel, anhydrous pasty or solid products, a foam, in particular an aerosol or a spray.
Elle peut en outre contenir d'autres ingrédients actifs, bien connus de l'homme de l'art, pour renforcer et/ou compléter toute action cosmétique. It can also contain other active ingredients, well known to those skilled in the art, to strengthen and / or supplement any cosmetic action.
Ces ingrédients actifs seront choisis, par exemple parmi les conservateurs, les antioxydants, les charges minérales, les pigments, les filtres UV, les absorbeurs d'odeur, les colorants et les polymères liposolubles notamment hydrocarbonés. These active ingredients will be chosen, for example, from preservatives, antioxidants, mineral fillers, pigments, UV filters, odor absorbers, dyes and liposoluble polymers, especially hydrocarbon-based polymers.
L'invention concerne également l'utilisation d'une base galénique active selon l'invention, en tant que produit complémentaire ou auxiliaire à une opération de massage de toute partie superficielle du corps humain, à des fins thérapeutiques, hygiéniques ou cosmétiques. The invention also relates to the use of an active galenic base according to the invention, as a complementary or auxiliary product to a massage operation of any surface part of the human body, for therapeutic, hygienic or cosmetic purposes.
Les caractéristiques et avantages de la présente invention sont à présent mis en évidence par les formulations ci-dessous décrites et les résultats obtenus sur différents sujets. The characteristics and advantages of the present invention are now demonstrated by the formulations described below and the results obtained on various subjects.
Exemple 1: Base galénique active, du type masque Arachidyl alcohol/behenyl alcohol/Arachidyl glucoside 3,00 % PEG-1 00 stearate/glyceryl stearate 2,00 % Isostearate d'isostearyle 5,00 % Huile de Paraffine 5,00 % Dimethicone 2,00 % Eau qsp 100 Conservateur qsp Kératorégulateur ursolate de calcium 0,05 % Fraction volatile parfumée - composition parfumée n 2 0,15 % Hydratant - glycérine 3,00 % - xylitol 4,00 % Protocole d'application Le masque est appliqué sur les zones à traiter par massage, dans le cadre d'un procédé d'atténuation des rides, 10 à 15 minutes avant la séance. 35 Après ces 10 à 1 5 minutes de pose, I'excédent est retiré. Example 1: Active galenic base, of the mask type Arachidyl alcohol / behenyl alcohol / Arachidyl glucoside 3.00% PEG-1 00 stearate / glyceryl stearate 2.00% Isostearyl isostearate 5.00% Paraffin oil 5.00% Dimethicone 2.00% Water qs 100 Preservative qs Calcium ursolate keratoregulator 0.05% Scented volatile fraction - scented composition n 2 0.15% Moisturizer - glycerin 3.00% - xylitol 4.00% Application protocol The mask is applied on the areas to be treated by massage, as part of a wrinkle reduction process, 10 to 15 minutes before the session. 35 After these 10 to 15 minutes of exposure, the excess is removed.
Le massage est effectué.The massage is performed.
Les séances sont répétées 2 fois par semaine, pendant 30 minutes. The sessions are repeated twice a week, for 30 minutes.
Un essai avec le même protocole de massage est effectué sans application l1 préalable du masque. A test with the same massage protocol is carried out without prior application of the mask.
Le point de déclenchement, c'est-à-dire le moment o des effets visibles sont constatés est plus précoce avec application du masque que sans application du masque, d'environ 3 semaines en moyenne. The trigger point, that is to say the moment when visible effects are observed, is earlier with application of the mask than without application of the mask, around 3 weeks on average.
On note également dans le groupe avec application du masque un allongement de la durée des effets, et la possibilité d'espacer les séances pour un même résultat. We also note in the group with application of the mask an extension of the duration of the effects, and the possibility of spacing the sessions for the same result.
Exemple 2: Base galénique active, du type fluide drainant Eau Carbopol Ultrez 10 (sol. A 2 %) Triéthanolamine NaOH 24% Dipalmitoyl hydroxyproline Isononyl isononanoate Acrylates copolymere Mélange de Phenoxyethanol & parabenes Kératorégulateur - ursolate de calcium Fraction volatile parfumée - composition parfumée n 2 Hydratant - xylitol - liftiline (peptide de blé) qsp 100 25.00 % 0.50 % 0.30 % 1.00 % 3.00 % 1.30 % 0.50 % 0,01 % 0,10 % 5,00 % 2,00 % Protocole d'application: Le fluide drainant est appliqué à l'endroit du massage, immédiatement avant ou pendant le massage. Les séances sont répétées 2 fois par 30 semaine, pendant 30 minutes. Example 2: Active galenic base, of the draining fluid type Water Carbopol Ultrez 10 (sol. A 2%) Triethanolamine NaOH 24% Dipalmitoyl hydroxyproline Isononyl isononanoate Acrylates copolymer Mixture of Phenoxyethanol & parabens Keratoregulator - calcium ursolate Fragrant volatile fraction - fragrance composition n 2 Moisturizer - xylitol - liftiline (wheat peptide) qs 100 25.00% 0.50% 0.30% 1.00% 3.00% 1.30% 0.50% 0.01% 0.10% 5.00% 2.00% Application protocol: Draining fluid is applied at the massage site, immediately before or during the massage. The sessions are repeated 2 times per 30 weeks, for 30 minutes.
Un essai avec le même protocole de massage est effectué sans application du fluide. A test with the same massage protocol is performed without applying the fluid.
Le point de déclenchement, c'est-à-dire le moment o des effets visibles sont constatés est plus précoce avec application du fluide, que sans 35 application du fluide, d'environ 3 semaines en moyenne. The trigger point, that is to say the moment when visible effects are observed, is earlier with application of the fluid, than without application of the fluid, approximately 3 weeks on average.
On note également dans le groupe avec application du fluide un allongement de la durée des effets, et la possibilité d'espacer les séances pour un même résultat. We also note in the group with application of the fluid an extension of the duration of the effects, and the possibility of spacing the sessions for the same result.
D'autres exemples de compositions à usage externe selon l'invention sont donnés ci-dessous, sans que cela puisse limiter la portée de l'invention Exemple 3: Base galénique active, du type émulsion Montanov 68 (Cetearyl Alcohol and Cetearyl Glucoside 5.00 % Huile de Jojoba 5.00 % Isopropyl Palmitate 7.00 % Sepigel 305 (Polyacrylamide and C13-14 Isoparaffin and Laueth-7) 0.30 % Phenonip 0.50 % Eau qsp 100 % Kératorégulateur - CaCI2 0,50 % Fraction volatile parfumée - composition parfumée n 1 0,15 % Hydratant - glycérine 5,00 % Antiride - acétate de tocophérol 0,50 % vitamine A palmitate 0,20 % - algisium C (silicium organique) 2,00 % Adoucissant - allantoïne 0,10 % Protocole d'application Cette émulsion est appliquée quotidiennement le soir, entre deux séances 30 de massage, sur la totalité du visage et plus particulièrement sur les zones ayant été massées. Other examples of compositions for external use according to the invention are given below, without this limiting the scope of the invention Example 3: Active pharmaceutical base, of the Montanov 68 emulsion type (Cetearyl Alcohol and Cetearyl Glucoside 5.00% Jojoba oil 5.00% Isopropyl Palmitate 7.00% Sepigel 305 (Polyacrylamide and C13-14 Isoparaffin and Laueth-7) 0.30% Phenonip 0.50% Water qs 100% Keratoregulator - CaCI2 0.50% Volatile fragrance fraction - fragrance composition n 1 0.15 % Moisturizer - glycerin 5.00% Anti-wrinkle - tocopherol acetate 0.50% vitamin A palmitate 0.20% - algisium C (organic silicon) 2.00% Softener - allantoin 0.10% Application protocol This emulsion is applied daily in the evening, between two 30 massage sessions, on the entire face and more particularly on the areas that have been massaged.
Exemple 4: Composition à usage externe, du type gel Carbopol Ultrez 10 (sol. A 2 %) 25.00 % Triéthanolamine 0.50 % Ethanol 5.00 % Elestab CPN 0. 20 % EDTA (séquestrant) 0.10 % Eau qsp 100 % Kératorégulateur - gluconate de calcium 0,05 % Fraction volatile parfumée - composition parfumée n 2 0,25 % Amincissant - caféine 3,00 % Antiride - algisium C (silicium organique) 2,00 % Protocole d'application: Le gel est appliqué quotidiennement entre les séances de massage sur les 15 zones ayant été massées. Example 4: Composition for external use, of the Carbopol Ultrez 10 gel type (sol. A 2%) 25.00% Triethanolamine 0.50% Ethanol 5.00% Elestab CPN 0. 20% EDTA (sequestrant) 0.10% Water qs 100% Keratoregulator - calcium gluconate 0.05% Fragrant volatile fraction - fragrant composition n 2 0.25% Slimming - caffeine 3.00% Anti-wrinkle - algisium C (organic silicon) 2.00% Application protocol: The gel is applied daily between massage sessions out of the 15 areas that were massaged.
Exemple 5: Base galénique active, du type lotion Mono Propylène Glycol 1. 00 % Cetiol HE (PEG-7 Glyceryl Cocoate) 1.00 % Cétrimide BP 0.10 % Methyl Parabenne 0.20 % Eau qsp 100 % Kératorégulateur - CaCI2 0,05 % Fraction volatile parfumée - composition parfumée n 2 0,15 % Hydratant - glycérine 1,00 % Adoucissant - allantoïne 0,30 % Protocole d'application La lotion est appliquée avant et après les séances de massage, elle peut 35 être également appliquée quotidiennement sur les zones traitées entre deux séances de massage. Example 5 Active Galenic Base, of the Mono Propylene Glycol Lotion Type 1. 00% Cetiol HE (PEG-7 Glyceryl Cocoate) 1.00% Cetrimide BP 0.10% Methyl Parabenne 0.20% Water qs 100% Keratoregulator - CaCI2 0.05% Volatile Scented Fraction - perfumed composition n 2 0.15% Moisturizer - glycerin 1.00% Softener - allantoin 0.30% Application protocol The lotion is applied before and after massage sessions, it can also be applied daily to the treated areas between two massage sessions.
Exemple 6: Base galénique active, du type spray Eau qsp 100 NaOH 24% 0.30 % Dipalmitoyl hydroxyproline 1.00 % Isononyl isononanoate 3.00 % Acrylates copolymere 1.30 % Mélange de Phenoxyethanol & parabenes 0.50 % Kératorégulateur - ursolate de calcium 0,01 % Fraction volatile parfumée composition parfumée nO 2 0,10 % Hydratant (tenseur) - liftiline (peptide de blé) 2,00 % Amincissant - escine 0,50 % Protocole d'application Le spray est utilisé avant les séances de massage ou après celles-ci sur les zones devant être massées ou devant être massées. Example 6: Active galenic base, of the spray type Water qs 100 NaOH 24% 0.30% Dipalmitoyl hydroxyproline 1.00% Isononyl isononanoate 3.00% Acrylates copolymer 1.30% Mixture of Phenoxyethanol & parabens 0.50% Keratoregulator - calcium ursolate 0.01% Fragile volatile fraction composition scented nO 2 0.10% Moisturizer (tensor) - liftiline (wheat peptide) 2.00% Slimming - escine 0.50% Application protocol The spray is used before or after massage sessions on the areas to be massaged or to be massaged.
Claims (18)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0307339A FR2856296B1 (en) | 2003-06-18 | 2003-06-18 | A COSMETIC CARE PROCESS WHICH CONJUGES A MECHANICAL EFFECT RESULTING FROM MASSAGE TO BIOLOGICAL EFFECTS IN COMPLEMENT OR RELAY |
| PCT/FR2004/001535 WO2004112743A2 (en) | 2003-06-18 | 2004-06-18 | Cosmetic care method combining a mechanical effect resulting from a massage, with complementary or relaying biological effects |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0307339A FR2856296B1 (en) | 2003-06-18 | 2003-06-18 | A COSMETIC CARE PROCESS WHICH CONJUGES A MECHANICAL EFFECT RESULTING FROM MASSAGE TO BIOLOGICAL EFFECTS IN COMPLEMENT OR RELAY |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2856296A1 true FR2856296A1 (en) | 2004-12-24 |
| FR2856296B1 FR2856296B1 (en) | 2007-09-07 |
Family
ID=33484529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR0307339A Expired - Lifetime FR2856296B1 (en) | 2003-06-18 | 2003-06-18 | A COSMETIC CARE PROCESS WHICH CONJUGES A MECHANICAL EFFECT RESULTING FROM MASSAGE TO BIOLOGICAL EFFECTS IN COMPLEMENT OR RELAY |
Country Status (2)
| Country | Link |
|---|---|
| FR (1) | FR2856296B1 (en) |
| WO (1) | WO2004112743A2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007007614A1 (en) * | 2007-02-13 | 2008-08-14 | Beiersdorf Ag | Process for the maintenance and protection of physiological skin balance and / or activation of skin regeneration |
| DE102007007610A1 (en) * | 2007-02-13 | 2008-08-14 | Beiersdorf Ag | Method for increasing the skin elasticity and / or strengthening the elasticity of the skin |
| DE102010036179A1 (en) * | 2010-09-02 | 2012-03-08 | Beiersdorf Ag | Cosmetic preparations with a calming effect |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1603765A (en) * | 1968-11-18 | 1971-05-24 | Cosmetics contg fatty acids, cholesterol and cystine | |
| FR2413093A1 (en) * | 1977-12-29 | 1979-07-27 | Cytho Sarl | Slimming products contg. extract of Centella asiatica - used as lotion or cream applied locally and externally |
| FR2576212A1 (en) * | 1985-01-21 | 1986-07-25 | Simard Jean Pierre | Method and product for slimming, containing essential oils |
| FR2680686A1 (en) * | 1991-08-28 | 1993-03-05 | Oreal | THREE-PHASE LOTION FOR BODY, PHARMACEUTICAL OR COSMETIC USE. |
| JPH09302377A (en) * | 1996-05-08 | 1997-11-25 | Pola Chem Ind Inc | Stress-relaxing perfume and composition containing the same |
| DE19633333A1 (en) * | 1996-08-06 | 1998-02-12 | Taxor Cosmetic Ag | Two-phase body-care tonic |
| FR2791260A1 (en) * | 1999-03-26 | 2000-09-29 | Dior Christian Parfums | COSMETIC OR DERMATOLOGICAL COMPOSITIONS CONTAINING AT LEAST ONE SUBSTANCE INTENDED TO INCREASE THE FUNCTIONALITY AND / OR EXPRESSION OF CD44 MEMBRANE RECEPTORS OF SKIN CELLS |
| JP2001049286A (en) * | 1999-08-05 | 2001-02-20 | Pola Chem Ind Inc | Perfume composition for stress relaxation and composition containing the same |
| FR2801214A1 (en) * | 1999-11-24 | 2001-05-25 | Ravishekhaz Shrivastava | Rapid reduction of stomach diameter, comprises a synergistic combination of an oral preparation containing plant extracts and clay and a local preparation containing essential oils and gel |
| FR2809952A1 (en) * | 2000-06-09 | 2001-12-14 | Louis Paul Guitay | Massager for human or animal use has suction chamber and rollers, at least one of which is driven by motor and reduction gear assembly |
| WO2002049600A1 (en) * | 2000-12-20 | 2002-06-27 | Quest International B.V. | Perfume compositions |
-
2003
- 2003-06-18 FR FR0307339A patent/FR2856296B1/en not_active Expired - Lifetime
-
2004
- 2004-06-18 WO PCT/FR2004/001535 patent/WO2004112743A2/en active Application Filing
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1603765A (en) * | 1968-11-18 | 1971-05-24 | Cosmetics contg fatty acids, cholesterol and cystine | |
| FR2413093A1 (en) * | 1977-12-29 | 1979-07-27 | Cytho Sarl | Slimming products contg. extract of Centella asiatica - used as lotion or cream applied locally and externally |
| FR2576212A1 (en) * | 1985-01-21 | 1986-07-25 | Simard Jean Pierre | Method and product for slimming, containing essential oils |
| FR2680686A1 (en) * | 1991-08-28 | 1993-03-05 | Oreal | THREE-PHASE LOTION FOR BODY, PHARMACEUTICAL OR COSMETIC USE. |
| JPH09302377A (en) * | 1996-05-08 | 1997-11-25 | Pola Chem Ind Inc | Stress-relaxing perfume and composition containing the same |
| DE19633333A1 (en) * | 1996-08-06 | 1998-02-12 | Taxor Cosmetic Ag | Two-phase body-care tonic |
| FR2791260A1 (en) * | 1999-03-26 | 2000-09-29 | Dior Christian Parfums | COSMETIC OR DERMATOLOGICAL COMPOSITIONS CONTAINING AT LEAST ONE SUBSTANCE INTENDED TO INCREASE THE FUNCTIONALITY AND / OR EXPRESSION OF CD44 MEMBRANE RECEPTORS OF SKIN CELLS |
| JP2001049286A (en) * | 1999-08-05 | 2001-02-20 | Pola Chem Ind Inc | Perfume composition for stress relaxation and composition containing the same |
| FR2801214A1 (en) * | 1999-11-24 | 2001-05-25 | Ravishekhaz Shrivastava | Rapid reduction of stomach diameter, comprises a synergistic combination of an oral preparation containing plant extracts and clay and a local preparation containing essential oils and gel |
| FR2809952A1 (en) * | 2000-06-09 | 2001-12-14 | Louis Paul Guitay | Massager for human or animal use has suction chamber and rollers, at least one of which is driven by motor and reduction gear assembly |
| WO2002049600A1 (en) * | 2000-12-20 | 2002-06-27 | Quest International B.V. | Perfume compositions |
Non-Patent Citations (2)
| Title |
|---|
| PATENT ABSTRACTS OF JAPAN vol. 1998, no. 03 27 February 1998 (1998-02-27) * |
| PATENT ABSTRACTS OF JAPAN vol. 2000, no. 19 5 June 2001 (2001-06-05) * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004112743A2 (en) | 2004-12-29 |
| FR2856296B1 (en) | 2007-09-07 |
| WO2004112743A3 (en) | 2005-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2312528C (en) | Cosmetic toning compound containing at least one hydroxystilbene in association with ascorbic acid | |
| CA2167980C (en) | Cgrp antagonist used in a cosmetic composition; pharmaceutical or dermatologic composition produced | |
| CA2148652C (en) | Substance p antagonist used in a cosmetic composition; composition thus produced | |
| EP1759688A1 (en) | Cosmetic method for the care of greasy skin and kit therefor | |
| FR2799369A1 (en) | COMBINATION OF ESCINE AND DEXTRAN SULFATE AND THE USE THEREOF | |
| EP0938891B1 (en) | Cosmetic composition containing cinnamic acid and its use | |
| CA2234797A1 (en) | Topical composition containing capsazepine | |
| FR2956818A1 (en) | Cosmetic use of peptide hydrolyzate from flax (Linum kind), as active agent in composition to soothe the skin, to prevent the damage or restore the skin barrier function and for preventing or treating skin inflammations e.g. reddening | |
| CA2245206C (en) | Use of an inhibitor of excitatory amino acids in a cosmetic or dermatological compound for sensitive skin, and the compound thus obtained | |
| EP0769293B1 (en) | Use of at least a beta-adrenergic agonist as an antagonist of substance P | |
| FR2991870A1 (en) | PROCESS FOR TREATING FAT SKIN | |
| FR2947727A1 (en) | Composition, useful for treating skin aging, wrinkles and fine line on the skin of the face, neck and/or neckline, comprises combination of an active agent of quercetol type and a protein hydrolyzate of cotton or its extract and excipient | |
| FR3018189A1 (en) | COSMETIC / DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST ONE ESSENTIAL OIL OF CISTE AND ITS USE | |
| FR2738742A1 (en) | USE OF AT LEAST ONE VICHY THERMAL WATER AS AN ANTAGONIST OF SUBSTANCE P | |
| FR2775594A1 (en) | USE OF A COMPOUND INHIBITING THE ACTIVITY OF A SODIUM CHANNEL OR A CALCIUM CHANNEL IN A TOPICAL USE COMPOSITION | |
| FR2847816A1 (en) | Composition useful for topical treatment of skin to control wrinkles and treat loss of firmness or elasticity, comprising specific pseudopeptide and stimulator of elastin biosynthesis | |
| JP2001207188A (en) | Perfume composition for eliminating lipid peroxide | |
| FR2856296A1 (en) | COSMETIC CARE PROCESS WHICH COMBINES A MECHANICAL EFFECT, RESULTING FROM A MASSAGE, WITH BIOLOGICAL EFFECTS IN COMPLEMENT OR RELAY | |
| FR2903009A1 (en) | Cosmetic and/or dermatological composition comprises useful e.g. to treat skin pathologies related to abnormal exfoliation, such as the xerosis, ichtyosis, psoriasis, atopic dermatitis, a desquamating agent and a C-glycoside derivative | |
| FR3005408A1 (en) | USE OF PETROSELINIC ACID TO COMBAT THE AESTHETIC DISORDERS OF SILHOUETTE ASSOCIATED WITH MODIFICATIONS OF ADIPOSE TISSUE | |
| FR3004347A1 (en) | COSMETIC COMPOSITION COMPRISING ESSENTIAL OIL OF SAGE AND USE THEREOF | |
| KR102419399B1 (en) | Cica-care cream composition and manufacturing method thereof | |
| FR2853242A1 (en) | COSMETIC PROCESS FOR PREVENTING AND / OR TREATING SKIN SIGNS OF AGING AND / OR STRESS USING COMPOSITIONS APPLIED TO ACUPUNCTURE POINTS OF THE FACE AND / OR NECK | |
| KR20040043596A (en) | Anti-keratin composition comprising cellulose as a effective component | |
| FR2882928A1 (en) | Cosmetic composition, useful to regenerate, restructure and stimulate derma, comprises palmitoyl-3-pentapeptide in combination with Centella asiatica extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 14 |
|
| PLFP | Fee payment |
Year of fee payment: 15 |
|
| PLFP | Fee payment |
Year of fee payment: 16 |
|
| PLFP | Fee payment |
Year of fee payment: 18 |
|
| PLFP | Fee payment |
Year of fee payment: 19 |
|
| PLFP | Fee payment |
Year of fee payment: 20 |
|
| AU | Other action affecting the ownership or exploitation of an industrial property right |
Effective date: 20231016 |
|
| CL | Concession to grant licences |
Name of requester: NAOS, FR Effective date: 20231016 Name of requester: NAOS INSTITUTE OF LIFE SCIENCE, FR Effective date: 20231016 |